Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitShares OutstandingShares Outstanding
Ratios

Goldenwell Biotech (GWLL) Long-Term Debt Issuances (2023 - 2024)

Goldenwell Biotech's Long-Term Debt Issuances history spans 2 years, with the latest figure at -$49250.0 for Q4 2024.

  • For Q4 2024, Long-Term Debt Issuances fell 415.95% year-over-year to -$49250.0; the TTM value through Dec 2024 reached $15588.0, down 79.38%, while the annual FY2023 figure was $75588.0, 277.94% up from the prior year.
  • Long-Term Debt Issuances reached -$49250.0 in Q4 2024 per GWLL's latest filing, down from $49250.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $49250.0 in Q2 2024 to a low of -$49250.0 in Q4 2024.